Wenxiao Jiang

Wenzhou, 325027, China

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 28 publications

TRAIL-driven targeting and reversing cervical cancer radioresistance by seleno-nanotherapeutics through regulating cell metabolism.

TRAIL-driven targeting and reversing cervical cancer radioresistance by seleno-nanotherapeutics through regulating cell metabolism.

Journal: Drug resistance updates : reviews and commentaries in antimicrobial and anticancer chemotherapy

Published: August 06, 2023

SH3 domain-binding kinase 1 promotes proliferation and inhibits apoptosis of cervical cancer via activating the Wnt/β-catenin and Raf/ERK1/2 signaling pathways.

SH3 domain-binding kinase 1 promotes proliferation and inhibits apoptosis of cervical cancer via activating the Wnt/β-catenin and Raf/ERK1/2 signaling pathways.

Journal: Molecular carcinogenesis

Published: November 17, 2022

Quantification and influencing factors of perioperative hidden blood loss in patients undergoing laparoscopic ovarian cystectomy for benign ovarian tumours.

Quantification and influencing factors of perioperative hidden blood loss in patients undergoing laparoscopic ovarian cystectomy for benign ovarian tumours.

Journal: Journal of obstetrics and gynaecology : the journal of the Institute of Obstetrics and Gynaecology

Published: August 11, 2022

MRVI1 and NTRK3 Are Potential Tumor Suppressor Genes Commonly Inactivated by DNA Methylation in Cervical Cancer.

MRVI1 and NTRK3 Are Potential Tumor Suppressor Genes Commonly Inactivated by DNA Methylation in Cervical Cancer.

Journal: Frontiers in oncology

Published: October 26, 2021

Clinicopathological Features and Survival of Adolescent and Young Adults with Cervical Cancer.

Clinicopathological Features and Survival of Adolescent and Young Adults with Cervical Cancer.

Journal: Cancer control : journal of the Moffitt Cancer Center

Published: October 14, 2021

E26 transformation-specific variant 4 as a tumor promotor in human cancers through specific molecular mechanisms.

E26 transformation-specific variant 4 as a tumor promotor in human cancers through specific molecular mechanisms.

Journal: Molecular therapy oncolytics

Published: September 23, 2021

The role of lncRNAs and circRNAs in the PD-1/PD-L1 pathway in cancer immunotherapy.

The role of lncRNAs and circRNAs in the PD-1/PD-L1 pathway in cancer immunotherapy.

Journal: Molecular cancer

Published: June 11, 2021

The roles of PD-1/PD-L1 in the prognosis and immunotherapy of prostate cancer.

The roles of PD-1/PD-L1 in the prognosis and immunotherapy of prostate cancer.

Journal: Molecular therapy : the journal of the American Society of Gene Therapy

Published: January 13, 2021

Discovery of key genes as novel biomarkers specifically associated with HPV-negative cervical cancer.

Discovery of key genes as novel biomarkers specifically associated with HPV-negative cervical cancer.

Journal: Molecular therapy. Methods & clinical development

Published: October 20, 2020

Overexpression of Galectin10 Predicts a Better Prognosis in Human Ovarian Cancer.

Overexpression of Galectin10 Predicts a Better Prognosis in Human Ovarian Cancer.

Journal: Journal of Cancer

Published: October 16, 2020

Effects of propofol on the development of cancer in humans.

Effects of propofol on the development of cancer in humans.

Journal: Cell proliferation

Published: April 19, 2020

RBR E3 ubiquitin ligases in tumorigenesis.

RBR E3 ubiquitin ligases in tumorigenesis.

Journal: Seminars in cancer biology

Published: April 06, 2020

Showing 1-12 of 28

Last Updated: 09/26/2026